Trianni
Powerful platform for the isolation of fully-human monoclonal antibodies.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD123m (Public information from Nov 2020)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$90.0m Valuation: $90.0m | Acquisition | ||
Total Funding | - |
Related Content
Recent News about Trianni
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.